Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,620,448 shares of the company's stock, valued at approximately $137,236,000. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.24% of Corteva at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Persistent Asset Partners Ltd acquired a new stake in shares of Corteva in the 2nd quarter worth about $76,000. OneDigital Investment Advisors LLC bought a new position in Corteva in the 2nd quarter valued at about $603,000. Plato Investment Management Ltd acquired a new position in Corteva during the 2nd quarter valued at about $3,245,000. Bell Investment Advisors Inc acquired a new position in Corteva during the 2nd quarter valued at about $41,000. Finally, Simplicity Wealth LLC bought a new stake in Corteva during the 2nd quarter worth approximately $329,000. 81.54% of the stock is owned by institutional investors.
Corteva Stock Up 2.6%
Shares of NYSE:CTVA opened at $77.97 on Wednesday. The company has a market capitalization of $52.02 billion, a PE ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The business has a fifty day moving average price of $81.84 and a two-hundred day moving average price of $80.12.
Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm's quarterly revenue was down 1.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.
Corteva Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva's dividend payout ratio is 47.68%.
Wall Street Analysts Forecast Growth
CTVA has been the subject of several analyst reports. Zacks Research downgraded Corteva from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 11th. Weiss Ratings cut Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research report on Monday, August 3rd. Citigroup increased their price target on Corteva from $85.00 to $86.00 and gave the company a "neutral" rating in a research report on Monday, August 3rd. BMO Capital Markets raised their price objective on Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a research note on Monday, August 3rd. Finally, BNP Paribas Exane lifted their price objective on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, Corteva presently has a consensus rating of "Moderate Buy" and a consensus price target of $91.50.
Get Our Latest Stock Report on Corteva
Corteva Profile
(
Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.